Alp Invest Partners B.V. Imago Bio Sciences, Inc. Transaction History

Alp Invest Partners B.V.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$11.81 - $20.92 $712,296 - $1.26 Million	-60,313 Reduced 66.67%	30,156 $404,000
Q1 2022 May 13, 2022	BUY	$16.97 - $25.0 $1.54 Million - $2.26 Million	90,469 New	90,469 $1.74 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Alp Invest Partners B.V., based on Form 13F filings with the SEC.

Stay updated on Alp Invest Partners B.V. with notifications on news.